about
Sepiapterin reductase expression is increased in Parkinson's disease brain tissueNovel genetic loci underlying human intracranial volume identified through genome-wide associationMeta-analysis of Parkinson's disease: identification of a novel locus, RIT2.Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.Genomewide association study for onset age in Parkinson disease.Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.Copy number variation in familial Parkinson disease.Genomewide association study for susceptibility genes contributing to familial Parkinson diseaseHuntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study.Replication of association between ELAVL4 and Parkinson disease: the GenePD study.Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD StudyThe Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study.APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.Genetic analyses of longitudinal phenotype data: a comparison of univariate methods and a multivariate approach.Data mining, neural nets, trees--problems 2 and 3 of Genetic Analysis Workshop 15.The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reportsGenetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study.Two-stage approach for identifying single-nucleotide polymorphisms associated with rheumatoid arthritis using random forests and Bayesian networksCombined haplotype relative risk (CHRR): a general and simple genetic association test that combines trios and unrelated case-controls.Risk of Parkinson's disease after tamoxifen treatment.Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.Parental occurrence of stroke and risk of stroke in their children: the Framingham studyGenome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium.Estrogen-related and other disease diagnoses preceding Parkinson's diseaseIs DFNA5 a susceptibility gene for age-related hearing impairment?Identifying rare variants from exome scans: the GAW17 experience.Genetic variants of WNK4 in whites and African Americans with hypertension.Genome-wide analysis of genetic loci associated with Alzheimer disease.Association of NEDD4L ubiquitin ligase with essential hypertension.Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium.Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.Postmortem Interval Influences α-Synuclein Expression in Parkinson Disease Brain.Common variants at 12q14 and 12q24 are associated with hippocampal volume.Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure.Ischemic stroke is associated with the ABO locus: the EuroCLOT studyCommon variants at 6q22 and 17q21 are associated with intracranial volume.HaploBuild: an algorithm to construct non-contiguous associated haplotypes in family based genetic studiesPolymorphisms in the promoter region of catalase gene and essential hypertension.
P50
Q24684947-D08426EE-3BF0-4154-99C5-9B440ECB9B0BQ27653381-8BEB22D2-F8A4-4060-8C65-4C1EBBC10489Q28262863-B59CD93C-8AE3-4423-812F-77B8CDC27EE6Q29417025-4EE99D4C-128A-4853-B500-14C6FB813A59Q29417034-EF22196F-109A-43DB-B090-80E170B114FFQ29417106-2B8DC4AB-3A0D-40AF-8AD3-4EF46F4D174DQ30425270-092CAC96-D4D6-4313-9EEE-74F0E60C6C65Q30431120-48DBE273-1AC7-4A2F-BB3C-1CD9443C1424Q30437480-A07A8837-03C6-4CE9-B0BF-676D979119DAQ30438950-08911A1E-9D47-4141-9B8A-43679413BB71Q30439050-9B6ADE8A-75B6-44FE-932E-685F2FE547ABQ30439341-A04C0E69-BC23-4235-BE9E-4DD71EB67607Q30440660-3B7AF24E-E973-49F7-A77E-88A7C8A3C733Q30448742-B9FCE775-F152-400A-AEE8-71ED122ABA93Q30655480-7844EBE6-23D8-4520-951B-A04705D1032EQ30907362-3BB65A8F-DFD5-4A3A-A854-131EFB54AA95Q31138120-958E6EE4-8C62-453F-9536-B487923D8D86Q33300809-038E4E8B-EDB9-4D1C-91F6-5BADAD0EE9B9Q33300810-30C75E93-22F2-4E10-AE85-847C5E44A949Q33333017-36B4C93D-11E3-44DF-A072-C0C52E3AB374Q33352742-0FBE59D0-5A0E-48AE-9E34-62FA04CED7DBQ33552831-EA96896F-1007-4974-88D9-F18FF468FC0BQ33747916-9A570BF4-4E66-419A-B9C3-FC527A77205BQ33813228-8BFD06A2-99E0-496B-845E-79FC73A0D4CFQ34071362-A1646F13-7738-499D-88C6-FCF5B9F242EFQ34144121-980BE0C7-7439-467A-BA63-A9ABB77878B0Q34162229-C8BF1253-3FB1-43DC-A16E-AAEB58962F06Q34176774-45D0DA3C-9ACD-4FF8-8113-40F8772260A6Q34193390-E52F1786-0E9D-4C29-90B1-62B55EA97C58Q34339530-3A8B74CA-DFBC-4994-B4DD-DA5B1A269B29Q34443485-C3043E16-CC33-49AB-AA1F-C8D106498CE0Q35065065-3A554B03-E163-4780-86E3-B93345B4FD22Q35354678-DFE23AA8-A83B-43E5-AD83-AE3132E32D3CQ35864260-33734104-226C-4972-8DE8-AF84C3C99642Q36189386-280CD277-4F3A-40B2-BBFE-7F55A5D34628Q36241862-2B5F5FB2-0BED-4A3D-86B4-2BBCB70AFF09Q36637803-80A7A35C-B7D7-4C18-AAD4-7371E4E90E26Q36744802-AEF3EAE3-2B11-4A30-BFCF-D72E702E7B84Q37149664-7AAD20CE-5C4C-4409-A44C-8CC93B5BFF99Q37365741-7E2F608F-D6DA-48F1-B624-661E3351F279
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anita L DeStefano
@ast
Anita L DeStefano
@en
Anita L DeStefano
@es
Anita L DeStefano
@nl
Anita L DeStefano
@sl
type
label
Anita L DeStefano
@ast
Anita L DeStefano
@en
Anita L DeStefano
@es
Anita L DeStefano
@nl
Anita L DeStefano
@sl
altLabel
Anita DeStefano
@en
Anita L. DeStefano
@en
DeStefano AL
@en
prefLabel
Anita L DeStefano
@ast
Anita L DeStefano
@en
Anita L DeStefano
@es
Anita L DeStefano
@nl
Anita L DeStefano
@sl
P106
P21
P31
P4012
P496
0000-0002-9335-2819